{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-25-000117","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.628856+00:00","generated_at":"2026-05-16T23:57:24.557261+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Maravai Q3 revenue $41.6M, net loss $45.1M, Adj EBITDA -$10.8M","bullets":["Revenue of $41.6 million, net loss of $45.1 million, and Adjusted EBITDA loss of $10.8 million for Q3 2025.","Full-year 2025 revenue guidance of approximately $185 million, excluding potential high-volume CleanCap orders.","CEO expects double-digit sequential revenue growth in Q4 2025, citing strong funnel and order velocity at TriLink.","Organizational restructuring and operating cost reduction initiatives remain on track."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-25-000117","json":"https://secwatch.observer/filing/0001823239-25-000117.json","markdown":"https://secwatch.observer/filing/0001823239-25-000117.md","text":"https://secwatch.observer/filing/0001823239-25-000117.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323925000117/0001823239-25-000117-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323925000117/mrvi-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:57:24.557261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}